Geographic Tongue Market Research Report - Global Forecast till 2027

Global Geographic Tongue Market Research Report, Diagnosis (Biopsy, Tests), Treatment (Topical Corticosteroids, Zinc Supplements, Topical Anaesthetic), End User (Hospitals & Clinics, Research Organization, Diagnostic Labs) - Global Forecast Till 2027

ID: MRFR/Pharma/3792-HCR | | Region: Global | 110 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Geographic tongue or migratory glossitis is a benign condition which is characterized by the inflammation of the tongue. Under normal conditions the tongue is covered by a layer of small bumps-papillae, which tend to be missing in this medical condition. The symptoms for geographic tongue are inclusive of general discomfort of the tongue or mouth and soreness or a burning sensation of the tongue, which is often worsened by spicy or acidic foods. The susceptibility of geographic tongue is high in patients with psoriasis. Moreover, it is estimated that the geriatric population is more frequently diagnosed for the same condition. Thus, the increasing prevalence of the psoriasis along with the growing geriatric population are the major drivers for the market growth. According to the International Federation of Psoriasis in 2016, approximately 3% of the world’s population suffer from psoriasis accounting to more than 125 million people across the globe. According to the World Health Organization the global geriatric population is growing and is estimated to reach a 1.5 billion by 2050 from 524 million in 2010. Additionally, growing oral healthcare expenditures are estimated to fuel the market growth during the forecast period. However, lack of awareness along with the limited availability of the treatment procedures and low per capita healthcare expenditure in the middle and low income countries are estimated to restrain the market growth during the forecast period.


The Geographic Tongue Market is estimated to grow at an Approximate CAGR of 10.6% from 2017 to 2023.


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Research and development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers

Figure 1:- Global Geographic Tongue Market share, by Region
Geographic Tongue Market


Sources: WHO, annual reports, press release, white paper, and company presentation


Key players for global geographic tongue market


Quest Diagnostics (U.S.), Sonic Healthcare (Australia), Merck KGaA (Germany), Jost Chemical Co. (U.S.), Pfizer Inc. (U.S.), AstraZeneca (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Danaher (U.S.) and others are some of the key players in the global geographic tongue market.


Segmentation


The Global Geographic Tongue Market is segmented on the basis of diagnosis, treatment, and end user.


On the basis of the diagnosis, the market is segmented into physical examinations, biopsy, tests, and others. The tests segment is sub-segmented into vitamin B testing, HLA B antigen testing, and others.


On the basis of the treatment, the market is segmented into topical corticosteroids, zinc supplements, topical anaesthetic, and others.


On the basis of the end user, the market is segmented into hospitals & clinics, research organization, diagnostic labs, and others.


Research Methodology
Geographic Tongue Market 2018


Sources: WHO, annual reports, press release, white paper, and company presentation


Regional Analysis


America dominates the global geographic tongue market owing to the presence of the developed healthcare sector and rising patient population for diseases like psoriasis. Moreover, increasing per capita healthcare expenditure followed by the presence of the developed economies like U.S. and Canada within the region boosts the market growth during the forecast period.


Europe stands second in the global geographic tongue market. Rising research and development in healthcare sector, increasing government funding and presence of huge patient population are the major drivers for the market growth within the region. According to a study published in the Archives of Dermatological Research in 2016, the prevalence of the psoriasis in Germany was about 2.5% affecting 2.0 million people within the region.


Asia Pacific region holds the fastest growing market. The region is marked with increasing healthcare expenditures and developing pharmaceutical & biotechnological sector and growing geriatric population. This, along with the presence of the developing economies like India and China provide huge opportunities for the market growth.


The Middle East & Africa hold the least share in the global geographic tongue market, which is attributed due the absence of developed healthcare services, especially in the African Region. A majority of the market share within this region is held by the Middle East. This can be attributed due to the huge healthcare expenditures by the developed economies like Kuwait, Qatar, Dubai and others within the region.



Frequently Asked Questions (FAQ) :


Geographic tongue market is projected to grow at a 10.6% CAGR between 2017-2023.

The Americas is expected to dominate the geographic tongue market.

Growing oral healthcare expenditure and rising prevalence of psoriasis are the key factors driving the geographic tongue market growth.

Limited accessibility of treatment and lack of awareness may limit the geographic tongue market growth.

Notable players profiled in the geographic tongue market include Danaher (US), Abbott (US), F. Hoffmann-La Roche Ltd (Switzerland), AstraZeneca (US), Pfizer Inc. (US), Jost Chemical Co. (US), Merck KGaA (Germany), Sonic Healthcare (Australia), and Quest Diagnostics (US).

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Geographic Tongue Market, by Diagnosis

6.1 Introduction

6.2 Physical Examinations

Market Estimates & Forecast, 2020 – 2027

6.3 Biopsy

Market Estimates & Forecast, 2020 – 2027

6.4 Tests

Market Estimates & Forecast, 2020 – 2027

6.4.1 Vitamin B Testing

6.4.2 HLA B Antigen Testing

6.4.3 Others

6.5 Others

Chapter 7. Global Geographic Tongue Market, by Treatment

7.1 Introduction

7.2 Topical Corticosteroids

Market Estimates & Forecast, 2020 – 2027

7.3 Zinc Supplements

Market Estimates & Forecast, 2020 – 2027

7.4 Topical Anesthetic

Market Estimates & Forecast, 2020 – 2027

7.5 Others

Chapter 8. Global Geographic Tongue Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

Market Estimates & Forecast, 2020 – 2027

8.3 Research Organization

Market Estimates & Forecast, 2020 – 2027

8.4 Diagnostic Labs

Market Estimates & Forecast, 2020 – 2027

8.5 Others

Chapter 9. Global Geographic Tongue Market, by Region

9.1 Introduction

9.2 The Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 U.K

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Quest Diagnostics

11.1.1 Company Overview

11.1.2 Treatment Overview

11.1.3 Financials

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Sonic Healthcare

11.2.1 Company Overview

11.2.2 Treatment Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Merck KGaA

11.3.1 Company Overview

11.3.2 Treatment Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Jost Chemical Co.

11.4.1 Company Overview

11.4.2 Treatment/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Pfizer Inc.

11.5.1 Company Overview

11.5.2 Treatment Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 AstraZeneca

11.6.1 Company Overview

11.6.2 Treatment Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 F. Hoffmann-La Roche Ltd

11.7.1 Overview

11.7.2 Treatment Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Abbott

11.8.1 Overview

11.8.2 Treatment Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Danaher

11.9.1 Overview

11.9.2 Treatment Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Geographic Tongue Industry

Chapter13 Appendix

LIST OF TABLES

Table 1 Global Geographic Tongue Industry Synopsis, 2020 – 2027

Table 2 Global Geographic Tongue Market Estimates and Forecast, 2020 – 2027, (USD Million)

Table 3 Global Geographic Tongue Market by Region, 2020 – 2027, (USD Million)

Table 4 Global Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)

Table 5 Global Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)

Table 6 Global Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)

Table 7 North America Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)

Table 8 North America Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)

Table 9 North America Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)

Table 10 U.S. Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)

Table 11 U.S. Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)

Table 12 U.S. Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)

Table 13 Canada Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)

Table 14 Canada Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)

Table 15 Canada Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)

Table 16 South America Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)

Table 17 South America Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)

Table 18 South America Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)

Table 19 Europe Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)

Table 20 Europe Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)

Table 21 Europe Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)

Table 22 Western Europe Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)

Table 23 Western Europe Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)

Table 24 Western Europe Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)

Table 25 Eastern Europe Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)

Table 26 Eastern Europe Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)

Table 27 Eastern Europe Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)

Table 28 Asia Pacific Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)

Table 29 Asia Pacific Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)

Table 30 Asia Pacific Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)

Table 31 Middle East & Africa Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)

Table 32 Middle East & Africa Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)

Table 33 Middle East & Africa Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Geographic Tongue Market

Figure 3 Segmentation Market Dynamics for Global Geographic Tongue Market

Figure 4 Global Geographic Tongue Market Share, by Diagnosis 2020

Figure 5 Global Geographic Tongue Market Share, by Treatment, 2020

Figure 6 Global Geographic Tongue Market Share, by End Users, 2020

Figure 7 Global Geographic Tongue Market Share, by Region, 2020

Figure 8 The Americas Geographic Tongue Market Share, by Country, 2020

Figure 9 Europe Geographic Tongue Market Share, by Country, 2020

Figure 10 Asia Pacific Geographic Tongue Market Share, by Country, 2020

Figure 11 Middle East & Africa Geographic Tongue Market Share, by Country, 2020

Figure 12 Global Geographic Tongue Market: Company Share Analysis, 2020 (%)

Figure 13 Quest Diagnostics: Key Financials

Figure 14 Quest Diagnostics: Segmental Revenue

Figure 15 Quest Diagnostics: Geographical Revenue

Figure 16 Sonic Healthcare: Key Financials

Figure 17 Sonic Healthcare: Segmental Revenue

Figure 18 Sonic Healthcare: Geographical Revenue

Figure 19 Merck KGaA: Key Financials

Figure 20 Merck KGaA: Segmental Revenue

Figure 21 Merck KGaA: Geographical Revenue

Figure 22 Jost Chemical Co.: Key Financials

Figure 23 Jost Chemical Co.: Segmental Revenue

Figure 24 Jost Chemical Co.: Geographical Revenue

Figure 25 Pfizer Inc.: Key Financials

Figure 26 Pfizer Inc.: Segmental Revenue

Figure 27 Pfizer Inc.: Geographical Revenue

Figure 28 AstraZeneca: Key Financials

Figure 29 AstraZeneca: Segmental Revenue

Figure 30 AstraZeneca: Geographical Revenue

Figure 31 F. Hoffmann-La Roche Ltd: Key Financials

Figure 32 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 33 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 34 Abbott: Key Financials

Figure 35 Abbott: Segmental Revenue

Figure 36 Abbott: Geographical Revenue

Figure 37 Danaher: Key Financials

Figure 38 Danaher: Segmental Revenue

Figure 39 Danaher: Geographical Revenue